New Delhi, April 16 -- Novo Nordisk has added around 2,000 employees so far this year as it reshapes its workforce following sweeping layoffs in 2025, according to a Bloomberg report.

The hiring marks a strategic shift for the Danish drugmaker, which ended last year with roughly 7,800 fewer employees after implementing its largest-ever round of job cuts under Chief Executive Officer Mike Doustdar. The layoffs were part of a broad restructuring effort aimed at streamlining operations and redirecting resources toward faster-growing segments, particularly its blockbuster diabetes and obesity drug portfolio.

According to Bloomberg, the latest recruitment drive reflects a more targeted approach to workforce planning, with Novo Nordisk focusi...